These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34521435)

  • 1. Colchicine - an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants.
    Welzel T; Wildermuth AL; Deschner N; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):142. PubMed ID: 34521435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.
    Welzel T; Ellinghaus M; Wildermuth AL; Deschner N; Benseler SM; Kuemmerle-Deschner JB
    Front Pediatr; 2021; 9():759664. PubMed ID: 34900867
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children.
    Goldberg O; Levinsky Y; Peled O; Koren G; Harel L; Amarilyo G
    Semin Arthritis Rheum; 2019 Dec; 49(3):459-463. PubMed ID: 31255241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE; Batu ED; Bilginer Y; Özen S
    Clin Rheumatol; 2017 Feb; 36(2):421-425. PubMed ID: 27679472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features predicting colchicine efficacy in treatment of children with undefined systemic autoinflammatory disease: A retrospective cohort study.
    Marques MC; Egeli BH; Wobma H; Ribeiro C; Anderson E; Hausmann JS; Dedeoğlu F
    Eur J Rheumatol; 2022 Jul; 9(3):116-121. PubMed ID: 35156637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
    Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
    Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
    Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
    Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Mediterranean Fever Is Commonly Diagnosed in Children in Israel with Periodic Fever Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome.
    Butbul Aviel Y; Harel L; Abu Rumi M; Brik R; Hezkelo N; Ohana O; Amarilyo G
    J Pediatr; 2019 Jan; 204():270-274. PubMed ID: 30361059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?
    Gunes M; Cekic S; Kilic SS
    Pediatr Int; 2017 Jun; 59(6):655-660. PubMed ID: 28207965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance.
    Sarı A; Bodakçi E; Armağan B; Satış H; Ataş N; Yaşar Bilge NŞ; Bilici Salman R; Yardımcı GK; Babaoğlu H; Kılıç L; Öztürk MA; Haznedaroğlu Ş; Göker B; Kalyoncu U; Kaşifoğlu T; Tufan A
    Turk J Med Sci; 2021 Aug; 51(4):1695-1701. PubMed ID: 33726481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients.
    Akbaba TH; Ustabas G; Kasap-Cuceloglu M; Ozen S; Balci-Peynircioglu B
    Mol Biol Rep; 2020 Nov; 47(11):9005-9011. PubMed ID: 33161498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
    Tal R; Semo Oz R; Amarilyo G; Eidlitz-Marcus T; Goldberg O; Levinsky Y; Peled O; Harel L
    Rheumatol Int; 2020 Jan; 40(1):121-128. PubMed ID: 31230112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could familial Mediterranean fever gene mutations be related to PFAPA syndrome?
    Celiksoy MH; Ogur G; Yaman E; Abur U; Fazla S; Sancak R; Yildiran A
    Pediatr Allergy Immunol; 2016 Feb; 27(1):78-82. PubMed ID: 26360812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
    Sag E; Akal F; Atalay E; Akca UK; Demir S; Demirel D; Batu ED; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2020 Nov; 59(11):3324-3329. PubMed ID: 32306038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments.
    Welzel T; Zapf B; Klotsche J; Satirer Ö; Benseler SM; Kuemmerle-Deschner JB
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673592
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
    Bonfrate L; Scaccianoce G; Palasciano G; Ben-Chetrit E; Portincasa P
    Eur J Clin Invest; 2017 Sep; 47(9):622-629. PubMed ID: 28678379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.